Cargando…

Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study

BACKGROUND: Liraglutide, a GLP-1 analogue, exerts several beneficial non-glycemic effects in patients with type-2 diabetes (T2DM), such as those on body weight, blood pressure, plasma lipids and inflammation markers. However, the effects of liraglutide on cardiovascular (CV) risk markers in subjects...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rizzo, Manfredi, Rizvi, Ali A., Patti, Angelo Maria, Nikolic, Dragana, Giglio, Rosaria Vincenza, Castellino, Giuseppa, Li Volti, Giovanni, Caprio, Massimiliano, Montalto, Giuseppe, Provenzano, Vincenzo, Genovese, Stefano, Ceriello, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135832/ https://www.ncbi.nlm.nih.gov/pubmed/27912784 http://dx.doi.org/10.1186/s12933-016-0480-8

Ejemplares similares

Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect
por: Nikolic, Dragana, et al.
Publicado: (2020)

Liraglutide Increases Serum Levels of MicroRNA-27b, -130a and -210 in Patients with Type 2 Diabetes Mellitus: A Novel Epigenetic Effect
por: Giglio, Rosaria Vincenza, et al.
Publicado: (2020)

Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study
por: Rizzo, Manfredi, et al.
Publicado: (2014)

Natural approaches in metabolic syndrome management
por: Patti, Angelo Maria, et al.
Publicado: (2017)

Management of Statin Intolerance in 2018: Still More Questions Than Answers
por: Toth, Peter P., et al.
Publicado: (2018)

Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study
por: Nikolic, Dragana, et al.
Publicado: (2022)

Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study
por: Toth, Peter P., et al.
Publicado: (2016)

Pasta Supplemented with Opuntia ficus-indica Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study
por: Giglio, Rosaria Vincenza, et al.
Publicado: (2020)

Altilix(®) Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study
por: Castellino, Giuseppa, et al.
Publicado: (2019)

A Nutraceutical Containing Chlorogenic Acid and Luteolin Improves Cardiometabolic Parameters in Subjects with Pre-obesity: A 6-Month Randomized, Double-Blind, Placebo-Controlled Study
por: Terzo, Simona, et al.
Publicado: (2023)

Lipoprotein Subfractions in Metabolic Syndrome and Obesity: Clinical Significance and Therapeutic Approaches
por: Nikolic, Dragana, et al.
Publicado: (2013)

Daily Use of Extra Virgin Olive Oil with High Oleocanthal Concentration Reduced Body Weight, Waist Circumference, Alanine Transaminase, Inflammatory Cytokines and Hepatic Steatosis in Subjects with the Metabolic Syndrome: A 2-Month Intervention Study
por: Patti, Angelo M., et al.
Publicado: (2020)

Statin treatment in the elderly: how much do we know?
por: Rizzo, Manfredi, et al.
Publicado: (2013)

Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes
por: Patti, Angelo Maria, et al.
Publicado: (2020)

Carotid intima-media thickness in patients with psoriasis with and without metabolic syndrome
por: Ramírez-Terán, Ana L., et al.
Publicado: (2022)

Novel Therapeutical Approaches to Managing Atherosclerotic Risk
por: Giglio, Rosaria Vincenza, et al.
Publicado: (2021)

Gender differences in association between metabolic syndrome and carotid intima media thickness
por: Tabatabaei-Malazy, Ozra, et al.
Publicado: (2012)

Carotid artery intima-media thickness and erectile dysfunction in patients with metabolic syndrome
por: Unal, Mustafa, et al.
Publicado: (2014)

Metabolic syndrome and carotid intima-media thickness in chronic obstructive pulmonary disease
por: Ozgen Alpaydin, Aylin, et al.
Publicado: (2013)

The Influence of Metabolic Syndrome Risk Factors on Carotid Intima Media Thickness in Children
por: Downing, Robert, et al.
Publicado: (2021)

The metabolic phenotype of the patient influences the reduction in carotid intima-media thickness achieved following metabolic surgery
por: Melchor-López, Alberto, et al.
Publicado: (2022)

An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes
por: Giglio, Rosaria Vincenza, et al.
Publicado: (2022)

Carotid Intima–Media Roughness and Elasticity in Hypertensive Patients With Normal Carotid Intima‐Media Thickness
por: Wu, Yu, et al.
Publicado: (2018)

Preliminary Results of CitraVes™ Effects on Low Density Lipoprotein Cholesterol and Waist Circumference in Healthy Subjects after 12 Weeks: A Pilot Open-Label Study
por: Raimondo, Stefania, et al.
Publicado: (2021)

Red blood cell distribution width and carotid intima-media thickness in patients with metabolic syndrome
por: Ren, Dongdong, et al.
Publicado: (2017)

Association between the intima-media thickness of the extracranial carotid arteries and metabolic syndrome in ethnic Kyrgyzs
por: Kerimkulova, Alina S., et al.
Publicado: (2018)

Angiogenin Levels and Carotid Intima-Media Thickness in Patients with Type 1 Diabetes and Metabolic Syndrome
por: Neubauer-Geryk, Jolanta, et al.
Publicado: (2023)

Infection with Helicobacter pylori may predispose to atherosclerosis: role of inflammation and thickening of intima-media of carotid arteries
por: Aramouni, Karl, et al.
Publicado: (2023)

Advances in the Pharmacological Management of Diabetic Nephropathy: A 2022 International Update
por: Giglio, Rosaria Vincenza, et al.
Publicado: (2023)

Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 Diabetes
por: Patti, Angelo Maria, et al.
Publicado: (2023)

Experimental and Emerging Free Fatty Acid Receptor Agonists for the Treatment of Type 2 Diabetes
por: Patti, Angelo Maria, et al.
Publicado: (2022)

Comparison of Carotid Intima-Media Thickness in Pediatric Patients with Metabolic Syndrome, Heterozygous Familial Hyperlipidemia and Normals
por: Vijayasarathi, Arvind, et al.
Publicado: (2014)

Carotid intima-media thickness values are significantly higher in patients with prediabetes compared to normal glucose metabolism
por: Bulut, Atilla, et al.
Publicado: (2019)

The relationship of carotid intima-media thickness with anthropometric and metabolic parameters in patients with classic congenital adrenal hyperplasia
por: TUHAN, Hale, et al.
Publicado: (2021)

Investigating the Relationship between Carotid Intima-Media Thickness (CIMT), Opium Addiction, and Components of the Metabolic Syndrome
por: Enhesari, Ahmad, et al.
Publicado: (2023)

Metabolic disorders during pregnancy and postpartum cardiometabolic risk
por: Patti, Angelo Maria, et al.
Publicado: (2018)

Metabolically healthy and metabolically unhealthy obese children both have increased carotid intima-media thickness: a case control study
por: Farello, Giovanni, et al.
Publicado: (2018)

Diabetes and Colorectal Cancer Risk: A New Look at Molecular Mechanisms and Potential Role of Novel Antidiabetic Agents
por: Vekic, Jelena, et al.
Publicado: (2021)

Hepatic fat content is a determinant of metabolic phenotypes and increased carotid intima-media thickness in obese adults
por: Zhang, Huijie, et al.
Publicado: (2016)

Carotid intima-media thickness and plasma fibrinogen among subjects with metabolic syndrome: Isfahan cohort study, Iran
por: Bayanfar, Zahra, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8a98u8as0rdmm14dfumgpef0ci